Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2019 | 10-2018 | 10-2017 | 10-2016 | 10-2015 | |
| Sales | 20,884 | 6,063 | 12,031 | 3,995 | 0 |
| Gross Profit | 20,884 | 6,063 | 12,031 | 3,995 | N/A |
| Operating Expenses | 38,856 | 76,442 | 110,477 | 80,487 | 48,699 |
| Operating Income | -17,972 | -70,379 | -98,446 | -76,492 | -48,699 |
| Other Income | 1,410 | 3,914 | 608 | 400 | 59 |
| Pre-tax Income | -16,562 | -66,465 | -97,838 | -76,092 | -48,641 |
| Income Tax | 50 | 50 | -4,403 | -2,536 | -1,609 |
| Net Income Continuous | -16,612 | -66,515 | -93,435 | -73,556 | -47,031 |
| Net Income | $-16,612 | $-66,515 | $-93,435 | $-73,556 | $-47,031 |
| EPS Basic Total Ops | -87.20 | -1,548.80 | -2,770.62 | -2,494.75 | -2,014.99 |
| EPS Basic Continuous Ops | -87.39 | -1,549.11 | -2,765.15 | -2,492.12 | -2,012.74 |
| EPS Diluted Total Ops | -87.20 | -1,548.80 | -2,770.62 | -2,494.75 | -2,014.99 |
| EPS Diluted Continuous Ops | -87.39 | -1,549.11 | -2,765.15 | -2,492.12 | -2,012.74 |
| EBITDA(a) | $-16,489 | $-68,884 | $-97,141 | $-75,703 | $-48,373 |